Episode
Episode 3: Gene Therapy’s Future: Will Patient Engagement Eclipse Science?
- Podcast
- Hypothesize That!
- Published
- Aug 4, 2025
- Duration seconds
- 1775
- Processing state
not_requested- Canonical source
- https://shows.acast.com/hypothesize-that/episodes/episode-3-gene-therapys-future-will-patient-engagement-eclip
Actions
POST https://stenobird.com/v1/public/podcasts/hypothesize-that-7842584/episodes/episode-3-gene-therapy-s-future-will-patient-engagement-eclipse-science/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hypothesize-that-7842584/episode-3-gene-therapy-s-future-will-patient-engagement-eclipse-science.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Is scientific innovation enough to drive the future of gene therapy, or is patient engagement the missing key? Join host Nicola Hill as she explores this question with Laurence Woollard, a rare disease advocate, and UCB’s Global Patient Engagement Lead, Dr. Emma Lane. Together, they discuss the critical role of patients in co-creating therapies that meet real-world needs, the ethical challenges of gene editing, and how early collaboration can build trust and transparency. Hear real-world insights into how patient voices are reshaping R&D—and how industry can embrace this paradigm shift. This podcast is produced and funded by UCB. Hosted on Acast. See acast.com/privacy for more information. IE-OT-2500003 – July 2025 Hosted on Acast. See acast.com/privacy for more information.